Do not stop or change your medication without speaking to a pharmacist or healthcare professional.

This is a historical report — it no longer reflects this drug's current status. Current status: Active Shortage. View this drug's full profile page →

Resolved

SANDOZ RABEPRAZOLE

SANDOZ CANADA INCORPORATED

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of SANDOZ RABEPRAZOLE in Canada?

Yes. SANDOZ RABEPRAZOLE 20MG has an active shortage reported to Health Canada (last updated November 9, 2026).

Why is SANDOZ RABEPRAZOLE not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will SANDOZ RABEPRAZOLE be available again?

The manufacturer's estimated resolution date is December 4, 2026. This is an estimate and can change; follow this page to get an email when the status changes.

Guide

Proton Pump Inhibitor (PPI) Shortage in Canada: Omeprazole, Pantoprazole, Rabeprazole

Why a shortage of one PPI brand rarely means the whole class is unavailable, when a pharmacist can swap manufacturers, and when it needs your prescriber.

Can I still get this?Check with your pharmacist
StatusResolved
Same-ingredient products on fileNone found
Affected strength20MG
Report last updated2026-09-21
Checked by MedShort2026-11-12

What this means

Does this mean the shortage is completely over everywhere?

It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.

What should I do?

If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.

Have you checked a pharmacy recently?

Recently found in stock

  • ✓ 2 days agoN0MRexall
  • ✓ 3 days agoRexall
  • ✓ 6 days agoM2K
  • ✓ 8 days agoL7E
  • ✓ 8 days ago

3 of 3 recent reports found it in stock (ON)

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02314185

Strength

20MG

Dosage Form

TABLET (ENTERIC-COATED)

Route

ORAL

Active Ingredient

RABEPRAZOLE SODIUM

Tier

Unrated

Last Updated

2026-09-21

Reason for Shortage

Disruption of the manufacture of the drug.